Space ionizing radiation related disease prediction and candidate drug screening method
By identifying key molecular networks and database analysis of space ionizing radiation, drugs with reverse radiation damage were predicted, which solved the problem of fewer existing anti-radiation drugs and major side effects, provided new drug screening methods, and reduced drug development costs and time.
Patent Information
- Application Number
- CN202411393451.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-08
- Publication Date
- 2024-11-12
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
There are fewer anti-radiation drugs and have great side effects, making it difficult to effectively predict and screen drugs with anti-radiation effects, and cannot effectively reduce the health risks of space ionizing radiation to the human body.
By identifying key molecules of space ionizing radiation, building their networks, analyzing the relationship with diseases, screening out significantly related diseases, using differentially expressed genes to predict candidate drugs with therapeutic effects, combining miR2Disease, DisGeNET, MeSH and other databases to build molecular networks and calculate Drug association scores, and drugs with reverse radiation damage were screened.
New candidates are provided for the selection of anti-radiation drugs, and the diseases and molecular mechanisms affected by space ionization radiation are explored, and drugs with the potential to alleviate damage to space ionization radiation are predicted, reducing the cost and time of drug development.
Smart Images

Figure CN118942734A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of space ionizing radiation technology, and in particular to a method for predicting space ionizing radiation-related diseases and screening candidate drugs. Background Art
[0002] Ionizing radiation from space can have serious adverse effects on various human systems, such as causing cataracts, cardiovascular diseases, etc., and may also increase the risk of cancer, posing a major hidden danger to human health. In view of the huge hazards of space ionizing radiation, the development of some easy-to-take anti-radiation drugs can increase the resistance of human cells to space ionizing radiation, reduce or prevent tissue damage, and reduce the risk of space ionizing radiation to a certain extent. However, there are currently few anti-radiation drugs available, and most of them also have significant side effects. Therefore, based on the study of the molecular mechanism of the impact of space ionizing radiation on diseases, it is an urgent practical need to use drug repositioning methods to screen drugs with the potential to alleviate space ionizing radiation damage. Summary of the invention
[0003] The present invention provides a method for predicting space ionizing radiation-related diseases and screening candidate drugs, which can overcome certain or some defects of the prior art.
[0004] A method for predicting space ionizing radiation-related diseases and screening candidate drugs according to the present invention comprises the following steps: 1. Identify key molecules of space ionizing radiation and build a network of key molecules of space ionizing radiation; 2. Conduct an overall analysis of the relationship between space ionizing radiation and diseases, and identify diseases related to space ionizing radiation; 3. Classify diseases related to space ionizing radiation and conduct statistical tests on each category of diseases to screen out diseases that are significantly related to space ionizing radiation; 4. Construct a molecular network of diseases significantly associated with space ionizing radiation; 5. Predict candidate drugs with therapeutic effects based on the differentially expressed genes in the molecular network.
[0005] Preferably, in step 2, the miR2Disease database is used to study diseases related to microRNAs (miRNAs) in key molecules of space ionizing radiation, and the DisGeNET database is used to study diseases related to genes and transcription factors (TFs) in key molecules of space ionizing radiation; a hypergeometric test is performed on the gene sets of key molecules of space ionizing radiation and the disease gene sets in the database to screen out related diseases.
[0006] Preferably, in step three, the screened diseases are classified using the medical subject heading list MeSH, and a hypergeometric test is performed on each disease category. Tumors and digestive system diseases are significantly associated with space ionizing radiation.
[0007] Preferably, in step 4, molecules significantly associated with tumors and their interactions are extracted from the key molecular network of space ionizing radiation, and a space ionizing radiation-tumor network is constructed; From the key molecular network of space ionizing radiation, molecules that are significantly related to digestive system diseases and their interactions are extracted to construct a space ionizing radiation-digestive system disease network.
[0008] As a preference, in step five, specifically: First, the differentially expressed genes in the key molecules of space ionizing radiation were used as the phenotypic molecular characteristics of space ionizing radiation; at the same time, the changes in gene expression in cells after drug treatment were arranged in descending order as the molecular characteristics of the drugs; then, the association score of each drug was calculated. Connectivity Score ( CS ), identify phenotypic molecular features and drug molecular features with opposite expression directions, and predict candidate drugs that can alleviate space ionizing radiation damage; CS The calculation formula is as follows: ; in, and Represents the enrichment scores of genes up-regulated and down-regulated by space ionizing radiation, respectively. Enrichment Score ( ES ); ES It reflects the enrichment of phenotypic molecular characteristics (up-regulated and down-regulated genes) of space ionizing radiation in drug molecular characteristics, which is calculated by the GSEA method.
[0009] If the up-regulated genes in the space ionizing radiation phenotype molecular signature are enriched in the upper half of the drug molecular signature, and the down-regulated genes are enriched in the lower half of the drug molecular signature, then this drug may simulate the adverse effects of space ionizing radiation on the human body. CS > 0; if the phenotypic molecular features are randomly distributed on the drug molecular features without obvious features, there is no significant relationship between the drug and space ionizing radiation. CS = 0; if the up-regulated genes in the phenotypic molecular signature are enriched in the lower half of the drug molecular signature, and the down-regulated genes are enriched in the upper half of the drug molecular signature, then this drug may reverse the adverse effects of space ionizing radiation on the human body. CS < 0.
[0010] The present invention explores the diseases affected by space ionizing radiation and their molecular mechanisms, and based on the key molecules of space ionizing radiation, predicts potential candidate drugs that can alleviate the damage caused by space ionizing radiation, providing more new candidates for the selection of anti-radiation drugs. BRIEF DESCRIPTION OF THE DRAWINGS
[0011] Figure 1 This is a flow chart of a method for predicting space ionizing radiation-related diseases and screening candidate drugs.
[0012] Figure 2 This is a diagram of a heterogeneous gene regulatory network; Note: purple triangles represent miRNAs, orange diamonds represent TFs, and green circles represent genes.
[0013] Figure 3 Schematic diagram of the key molecular network of space ionizing radiation; Note: The shape of the node indicates the type of molecule, the color indicates whether it is a seed node, and the size indicates the degree of the node.
[0014] Figure 4 Schematic diagram of the space ionizing radiation-tumor network; Note: red nodes represent molecules related to more than 5 diseases, nodes marked with multiple colors at the same time represent molecules related to 2 to 5 diseases, and other nodes marked with a single color represent molecules related to only one disease.
[0015] Figure 5 This is a schematic diagram of the space ionizing radiation-digestive system disease network; Note: Nodes colored in a single color represent molecules related to only one disease, and nodes marked with multiple colors at the same time represent molecules related to 2-3 diseases. The shape of the node indicates the type of molecule.
[0016] Figure 6 Schematic diagram of candidate small molecule drugs; Note: The numbers represent the association scores of the drugs Connectivity Score .
[0017] Figure 7 Schematic diagram of candidate Chinese medicine ingredients. Note: The numbers represent the normalized association scores of the drugs. Connectivity Score . DETAILED DESCRIPTION
[0018] In order to further understand the content of the present invention, the present invention is described in detail in conjunction with the accompanying drawings and embodiments. It should be understood that the embodiments are only for explaining the present invention and are not intended to limit it.
[0019] like Figure 1 As shown, this embodiment provides a method for predicting space ionizing radiation-related diseases and screening candidate drugs, which includes the following steps: 1. Identify key molecules of space ionizing radiation and build a network of key molecules of space ionizing radiation; 2. Conduct an overall analysis of the relationship between space ionizing radiation and diseases, and identify diseases related to space ionizing radiation; 3. Classify diseases related to space ionizing radiation and conduct statistical tests on each category of diseases to screen out diseases that are significantly related to space ionizing radiation; 4. Construct a molecular network of diseases significantly associated with space ionizing radiation; 5. Predict candidate drugs with therapeutic effects based on the differentially expressed genes in the molecular network.
[0020] In step one, specifically: 1) Perform differential expression analysis on the gene and miRNA expression profiles of space ionizing radiation, and screen for miRNAs and genes that are significantly differentially expressed under space ionizing radiation conditions; 2) Integrate the molecular interactions between transcription factors (TF), miRNA and genes to construct a heterogeneous gene regulatory network composed of these three biological molecules; 3) In the constructed heterogeneous gene regulatory network, the significantly differentially expressed miRNAs and genes are used as seed nodes to perform restarted random walks; 4) According to the score of each node in the network by the restarted walk algorithm, all the nodes in the network are sorted, and the top 1% of the nodes with the highest scores are screened out. These screened out nodes are the identified key molecules of space ionizing radiation, and the interaction relationships between the key molecules of space ionizing radiation are extracted to construct the key molecule network of space ionizing radiation.
[0021] In step 1), the R package limma V3.52.4 (Linear Models for Microarray Data) was used to perform differential expression analysis on the gene and miRNA expression profiles of space ionizing radiation, respectively.
[0022] limma uses linear models to describe gene expression levels and uses Bayesian methods to infer differences between genes. It uses the grouping factor, i.e., whether or not exposed to space ionizing radiation, as the independent variable and the gene expression data as the dependent variable. It uses the lmFit function to establish a weighted linear regression model for each gene, obtains the regression model coefficient, and associates the gene expression level with the grouping factor. It then uses the eBayes function to perform statistical inference on the model to obtain the expression difference of each gene. Finally, it uses the topTable function to perform Benjamini-Hochberg multiple test correction on each gene in the expression spectrum, and screens out genes with significant differential expression under space ionizing radiation conditions according to the set significance level. According to the calculation results of limma, the expression fold difference (Fold Change, FC ) and the adjusted significance level (Adjust p-value , adj.p ) is the threshold for screening differentially expressed genes. FC > 1 and adj.p Genes with a value <0.05 are up-regulated genes, which is consistent with log2 FC < -1 and adj.p Genes with a p<0.05 were down-regulated genes, and 43 genes with significant differential expression were screened out, of which 31 genes such as VWCE were up-regulated genes, and 12 genes such as EXO1 were down-regulated genes.
[0023] Use limma to perform differential expression analysis on miRNA expression profiles under space ionizing radiation conditions; adj.p < 0.05 is the significance level threshold, then no miRNA is significantly differentially expressed. This may be due to the small number of miRNAs in the expression profile, the large differences between samples, batch effects or sample heterogeneity in the calculation process, resulting in more miRNAs failing to reach the significance threshold when multiple testing correction is performed. p- value is the significance threshold. FC > 1 and p-value miRNAs with values < 0.05 are upregulated miRNAs, which are consistent with log2 FC < -1 and p-value < 0.05 were down-regulated miRNAs, and 7 significantly differentially expressed miRNAs were screened out, of which 6 were up-regulated miRNAs and only 1 was down-regulated miRNA.
[0024] In step 2), a heterogeneous gene regulatory network was constructed by integrating the TF-gene, miRNA-gene, TF-miRNA and gene-gene interactions obtained from the TRANSFAC, TarBase, miRTarBase, TransmiR and STRING databases and removing self-loops and duplicates. The network consisted of 17,939 nodes and 273,659 edges. The 17,939 nodes included 647 TFs, 888 miRNAs and 16,404 genes. In order to intuitively understand and analyze the complex relationships in the heterogeneous network, the Cytoscape software was used to visualize the constructed heterogeneous gene regulatory network, as shown in Figure 2. Figure 2 shown.
[0025] In step 3), the screened differentially expressed genes and differentially expressed miRNAs are used as seed nodes, and the restarted random walk algorithm is used on the constructed heterogeneous gene regulatory network to identify key molecules of space ionizing radiation.
[0026] When using the restarted random walk algorithm, you first need to define a seed set; the seed set includes one or more nodes in the network, which are the initial nodes of the random walk process, also known as seed nodes; starting from the defined seed node, in each walk process, the nodes can choose to move to their neighbor nodes, and will also jump back to the seed set with a certain probability; where the node moves to is related to the node weight, the degree distribution of the nodes in the network, and the restart probability; repeat the random walk process multiple times, when the sum of the differences of all nodes in two adjacent random walk processes is less than 1×10 -10 When , the network is considered to be in equilibrium; each node obtains an equilibrium probability, which represents the degree of correlation between the corresponding node and the seed node; the calculation formula of the restart random walk algorithm is as follows: ; in, is the adjacency matrix of the heterogeneous gene regulatory network; if two nodes have an interaction relationship in the network, the corresponding value is 1, if there is no interaction relationship between the two nodes, the corresponding value is 0, and the matrix is column-normalized; Represents the restart probability. According to prior knowledge, in this embodiment, the restart probability Set to 0.7; is the initialization vector, the length of which is the number of nodes in the network; Each component of the vector represents the initial score assigned to each node, The component of indicates whether the molecule is significantly differentially expressed in the expression profile; In the above equation, the components corresponding to the significantly differentially expressed molecules are set to 1 / n ,in n Represents the number of seed nodes. The components corresponding to molecules that are not differentially expressed are set to 0. Indicates t The score vector of each node after random walks; Indicates t -The score vector for each node after 1 random walk.
[0027] In step 4), there are a total of 17,939 nodes in the heterogeneous gene regulatory network. The scores of each node in the heterogeneous gene regulatory network are ranked in descending order from high to low by the restarted random walk algorithm, and the nodes ranked in the top 1% are selected, totaling 179, as key molecules of space ionizing radiation. In the final result of the restarted random walk algorithm, the nodes with higher scores not only have a high similarity with the seed nodes, but are also often "hub nodes" that play a key role in the network. Since miRNAs and genes that are significantly differentially expressed under space ionizing radiation conditions are used as seed nodes for restarting random walks, and nodes with higher scores are selected as key molecules, these key molecules are both related to space ionizing radiation and important nodes in the network.
[0028] These 179 key molecules of space ionizing radiation consist of 23 TFs, 10 miRNAs and 146 genes, as shown in Table 1. Among them, there are 50 seed nodes and 129 nodes expanded by the restarted random walk algorithm. From the heterogeneous gene regulatory network, 179 key molecules of space ionizing radiation and the interactions between these molecules were extracted to construct the key molecular network of space ionizing radiation. Figure 3 As shown, the space ionizing radiation key molecule network consists of 179 nodes and 1,318 edges.
[0029] Table 1: List of key molecules of space ionizing radiation ; In step 2, the miR2Disease database was used to study diseases related to microRNAs (miRNAs) in key molecules of space ionizing radiation, and the DisGeNET database was used to study diseases related to genes and TFs in key molecules of space ionizing radiation; the miR2Disease database provides a large amount of association information between miRNAs and different types of human diseases obtained through clinical trials, experimental studies, and literature retrieval. DisGeNET is a comprehensive database that provides disease-gene associations and disease-gene variant associations, containing 84,038 gene-disease associations involving 9,703 genes and 11,181 diseases. Hypergeometric tests were performed on the key molecule set of space ionizing radiation and the disease miRNA and gene sets in the database, and a total of 439 related diseases were screened out.
[0030] In step 3, the screened diseases were classified using the Medical Subject Headings (MeSH) to categorize them into 12 different categories, including tumors, digestive system diseases, congenital diseases, and nervous system diseases. A hypergeometric test was performed on each disease category, and only tumors and digestive system diseases were significantly associated with space ionizing radiation.
[0031] In step four, a specific analysis is conducted on the types of tumor diseases related to space ionizing radiation. There are a total of 168 tumor diseases that are significantly related to space ionizing radiation. According to the MeSH classification method based on tissue location, these tumors belong to 19 different cancer categories, including lymphoma, colorectal cancer, breast cancer, etc. A hypergeometric test was performed on the diseases in each category, and it was found that except for 4 types of tumors, such as sarcoma, gallbladder tumor, uterine tumor and thyroid tumor, the remaining 15 tumors were significantly related to space ionizing radiation. From the key molecular network of space ionizing radiation, the molecules related to these 15 tumors and their interactions were extracted to construct a space ionizing radiation-tumor network, such as Figure 4 The network includes 99 key molecules of space ionizing radiation related to tumors and 845 interactions between them.
[0032] Similarly, a specific analysis was conducted on digestive system diseases related to space ionizing radiation. There are 57 digestive system diseases significantly associated with space ionizing radiation, and these diseases are divided into five different categories according to the MeSH classification criteria. A hypergeometric test was performed on the diseases in each category, and it was found that three categories of diseases, including gastrointestinal diseases, liver diseases, and pancreatic diseases, were significantly associated with space ionizing radiation. The human digestive tract is very sensitive to the stimulation of ionizing radiation, so ionizing radiation can easily cause digestive system diseases. In particular, the small intestinal crypt cells, ionizing radiation kills these cells, causing mucosal damage, loss of epithelial shielding function, and exposure of the normal sterile lamina propria to luminal microorganisms, which in turn triggers an acute inflammatory response associated with immune cell infiltration, leading to the occurrence of digestive system diseases. The effects of ionizing radiation on the digestive system also include destroying intestinal flora and inducing acute gastrointestinal syndrome; causing excessive accumulation of lipid peroxides and depletion of unsaturated fatty acids, inducing "iron death" of gastrointestinal cells; causing damage to the upper digestive tract, causing acute mucosal damage, tissue fibrosis, and radiation esophagitis.
[0033] From the key molecular network of space ionizing radiation, the molecules related to these three digestive system diseases and their interactions were extracted to construct the space ionizing radiation-digestive system disease network, such as Figure 5 The network includes 84 key molecules of space ionizing radiation related to digestive system diseases and 742 interactions between them.
[0034] In step five, specifically: First, the differentially expressed genes in the key molecules of space ionizing radiation were used as the phenotypic molecular characteristics of space ionizing radiation; at the same time, the changes in gene expression in cells after drug treatment were arranged in descending order as the molecular characteristics of the drugs; then, the association score of each drug was calculated. Connectivity Score ( CS ), identify phenotypic molecular features and drug molecular features with opposite expression directions, and predict candidate drugs that can alleviate space ionizing radiation damage; CS The calculation formula is as follows: ; in, and Represents the enrichment scores of genes up-regulated and down-regulated by space ionizing radiation, respectively. Enrichment Score ( ES ); ES It reflects the enrichment of phenotypic molecular characteristics (up-regulated and down-regulated genes) of space ionizing radiation in drug molecular characteristics, which is calculated by the GSEA method.
[0035] If the up-regulated genes in the space ionizing radiation phenotype molecular signature are enriched in the upper half of the drug molecular signature, and the down-regulated genes are enriched in the lower half of the drug molecular signature, then this drug may simulate the adverse effects of space ionizing radiation on the human body. CS > 0; if the phenotypic molecular features are randomly distributed on the drug molecular features without obvious features, there is no significant relationship between the drug and space ionizing radiation. CS = 0; if the up-regulated genes in the phenotypic molecular signature are enriched in the lower half of the drug molecular signature, and the down-regulated genes are enriched in the upper half of the drug molecular signature, then this drug may reverse the adverse effects of space ionizing radiation on the human body. CS < 0.
[0036] Ionizing radiation from space can cause various tumors, digestive system diseases, and other types of diseases. It is necessary to develop drugs that can alleviate the damage caused by ionizing radiation from space. However, the development of new drugs specifically for ionizing radiation from space requires a lot of manpower, material resources, and financial resources, and requires a long research and development process and multiple rounds of clinical trials before it can be put into practical use. Drug repositioning, that is, discovering new indications for existing drugs, can greatly save the cost of drug development and shorten the time cycle. Next, this embodiment will screen some candidate drugs with the potential to reverse damage caused by ionizing radiation from space from two aspects: small molecule chemical drugs and traditional Chinese medicine ingredients.
[0037] Small molecule drug candidates Based on the above principles of drug prediction, this example uses the CMap (Connectivity Map) database to predict candidate small molecule drugs that alleviate space ionizing radiation damage. The CMap database provides an important platform and tool for systematically discovering the relationship between genes, small molecule compounds and diseases, clarifying the mechanism of action of drugs, discovering new drug treatment pathways, and promoting the development of personalized medicine.
[0038] The 76 up-regulated genes and 77 down-regulated genes in the key molecules of space ionizing radiation were used as the molecular characteristics of radiation phenotype. By comparing the Connectivity Score of each drug, the top 10 drugs with the greatest negative correlation with the molecular characteristics of radiation phenotype (Connectivity Score less than 0 and the largest absolute value) were screened, and candidate small molecule drugs with the potential to alleviate space ionizing radiation damage were obtained, namely Taurocholic-acid, LY-364947, Navitoclax, AGK-2, Taurodeoxycholic-acid, Tetradecylthioacetic-acid, Dienestrol, Parbendazole, VEGF-receptor-2-kinase-inhibitor-IV and Cholic-acid, as shown in Tables 2 and 3 . Figure 6 shown.
[0039] Table 2: List of candidate small molecule drugs ; By comparing the changes in gene expression before and after medication, it was found that Navitoclax reversed the expression of 13 genes such as NDC80 and BAX, which are key molecules of space ionizing radiation. In addition, studies have shown that Navitoclax can be used to treat diseases caused by ionizing radiation. The chest of mice was irradiated with a high dose of 6 Gy of ionizing radiation, which induced fibrosis of alveolar epithelial cells and caused pulmonary fibrosis in mice. After using Navitoclax on mice for 7 weeks, the degree of pulmonary fibrosis in mice was significantly reduced. After further analysis, it was found that Navitoclax can effectively remove fibrotic alveolar epithelial cells, improve pathological damage in the body, and treat pulmonary fibrosis by inhibiting the expression of anti-apoptotic genes BCL2 and Bcl-xL, killing senescent cells and inducing cell apoptosis. In addition, Navitoclax can also be used to treat diseases such as ionizing radiation-induced liver fibrosis, cardiac fibrosis, thrombocytopenia, and lymphoid malignancies.
[0040] Candidate Chinese herbal medicine ingredients This example uses the ITCM (Integrated Traditional Chinese Medicine) platform to predict candidate Chinese medicine ingredients with the potential to alleviate space ionizing radiation damage. ITCM is the largest drug transcriptomics platform based on active ingredients of Chinese medicine to date, covering more than 1,000 sets of expression profile data, including 496 active ingredients of Chinese medicine. The platform integrates six algorithms such as CMap, LINCS and Fisher to identify antagonistic disease-drug relationships. By performing multi-scale biological analysis, it can quickly identify potential active ingredients of Chinese medicine for treating specific diseases.
[0041] According to the differentially expressed genes in the key molecules of space ionizing radiation, the “CMap” drug identification method was selected based on the ITCM platform to screen out the top 10 Chinese herbal medicine ingredients with the smallest normalized Connectivity Score, which are Nuciferine, Hyoscyamine, Morroniside, Genistin, Cineole, Liquidambaric acid, Polyphyllin II, Saikosaponin D, Nodakenin, and Tenuifolin, as shown in Table 3 and Figure 7 shown.
[0042] Table 3: List of candidate Chinese herbal medicine ingredients ; Among these 10 candidate Chinese herbal ingredients, studies have reported the effectiveness of genistin and saikosaponin D in treating radiation damage.
[0043] Genistin, also known as genistein, is an isoflavone component abundant in soybeans. Because of its structure similar to estrogen, it is also called "phytoestrogen" and is often used as an angiogenesis inhibitor and anti-lipogenesis agent. Studies have shown that genistin promotes the dissociation of Bcl-xL and Beclin-1 by affecting the distribution of apoptotic protein Bcl-xL in the cytoplasm and nucleus, thereby activating the apoptosis process of cancer cells and having a good therapeutic effect on non-small cell lung cancer induced by ionizing radiation. In another study, after irradiating mice with 3 Gy of ionizing radiation, intestinal damage symptoms such as decreased survival rate of small intestinal crypt cells, shortened villi, and increased basal layer length appeared. Five days after genistin was injected, by scavenging oxidative free radicals derived from ionizing radiation, the production of free radical lipid peroxides was reduced, the changes in intestinal morphology of mice were improved, and the intestinal damage caused by ionizing radiation was alleviated.
[0044] Bupleurum saponin D is an effective monomer component extracted from the traditional Chinese medicine Bupleurum, which has anti-inflammatory, antibacterial, anti-tumor and anti-allergic properties. Studies have shown that in mice with liver cancer induced by ionizing radiation, Bupleurum saponin D can inhibit the proliferation of cancer cells, delay tumor growth, and produce more autophagosomes in cancer cells by inhibiting mTOR phosphorylation, increasing cancer cell apoptosis, and has a certain therapeutic effect on liver cancer caused by ionizing radiation.
[0045] This example explores the diseases affected by space ionizing radiation and their molecular mechanisms, and based on the key molecules of space ionizing radiation, predicts potential candidate drugs that can alleviate space ionizing radiation damage, providing more new candidates for the selection of anti-radiation drugs.
[0046] The present invention and its embodiments are described schematically above, and the description is not restrictive. The drawings show only one embodiment of the present invention, and the actual structure is not limited thereto. Therefore, if a person skilled in the art is inspired by it and designs a structural method and an embodiment similar to the technical solution without creativity without departing from the purpose of the invention, they shall all fall within the protection scope of the present invention.
Claims
1. A method for predicting space ionizing radiation-related diseases and screening candidate drugs, characterized in that: The following steps are involved:
1. Identify key molecules of space ionizing radiation and build a network of key molecules of space ionizing radiation; 2. Conduct an overall analysis of the relationship between space ionizing radiation and diseases, and identify diseases related to space ionizing radiation; 3. Classify diseases related to space ionizing radiation and conduct statistical tests on each category of diseases to screen out diseases that are significantly related to space ionizing radiation; 4. Construct a molecular network of diseases significantly associated with space ionizing radiation; 5. Predict candidate drugs with therapeutic effects based on the differentially expressed genes in the molecular network.
2. The method for predicting space ionizing radiation-related diseases and screening candidate drugs according to claim 1, characterized in that: In step 2, the miR2Disease database was used to study diseases related to microRNAs in key molecules of space ionizing radiation, and the DisGeNET database was used to study diseases related to genes and transcription factors in key molecules of space ionizing radiation. Hypergeometric tests were performed on the key molecular gene sets of space ionizing radiation and the disease gene sets in the database to screen out related diseases.
3. The method for predicting space ionizing radiation-related diseases and screening candidate drugs according to claim 2, characterized in that: In step three, the screened diseases were classified using the Medical Subject Headings (MeSH) table, and a hypergeometric test was performed on each disease category. Tumors and digestive system diseases were significantly associated with space ionizing radiation.
4. The method for predicting space ionizing radiation-related diseases and screening candidate drugs according to claim 3, characterized in that: In step 4, the molecules significantly associated with tumors and their interactions were extracted from the key molecular network of space ionizing radiation, and the space ionizing radiation-tumor network was constructed; From the key molecular network of space ionizing radiation, molecules that are significantly related to digestive system diseases and their interactions are extracted to construct a space ionizing radiation-digestive system disease network.
5. The method for predicting space ionizing radiation-related diseases and screening candidate drugs according to claim 4, characterized in that: In step five, specifically: First, the differentially expressed genes in the key molecules of space ionizing radiation were used as the phenotypic molecular characteristics of space ionizing radiation; at the same time, the changes in gene expression in cells after drug treatment were arranged in descending order as the molecular characteristics of the drugs; Then, the association score for each drug was calculated CS , identify phenotypic molecular features and drug molecular features with opposite expression directions, and predict candidate drugs that can alleviate space ionizing radiation damage; CS The calculation formula is as follows: ; in, and Represents the enrichment scores of up-regulated and down-regulated genes in response to space ionizing radiation ES ; ES It reflects the enrichment of phenotypic molecular features of space ionizing radiation in drug molecular features, which is calculated by GSEA method; If the up-regulated genes in the space ionizing radiation phenotype molecular signature are enriched in the upper half of the drug molecular signature, and the down-regulated genes are enriched in the lower half of the drug molecular signature, then this drug may simulate the adverse effects of space ionizing radiation on the human body. CS > 0; if the phenotypic molecular features are randomly distributed on the drug molecular features without obvious features, there is no significant relationship between the drug and space ionizing radiation. CS = 0; if the up-regulated genes in the phenotypic molecular signature are enriched in the lower half of the drug molecular signature, and the down-regulated genes are enriched in the upper half of the drug molecular signature, then this drug may reverse the adverse effects of space ionizing radiation on the human body. CS < 0.
Citation Information
Patent Citations
Method for identifying and predicting human genes related to space radiation damage protection drug target
CN111402954A
Method for researching osteosarcoma metastasis related gene signature and excavating potential drugs
CN112216348A
Heat storage for solar heating system - has separate storage elements for receiving and providing heat arranged in parallel or in series
DE2749714A1
Radiation meter
US3008051A
